| Dr Andy Truong Nguyen, MD | |
|
14131 Midway Rd, Suite 620, Addison, TX 75001-3623 | |
| (972) 249-0200 | |
| (972) 249-0206 |
| Full Name | Dr Andy Truong Nguyen |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 14131 Midway Rd, Addison, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831187061 | NPI | - | NPPES |
| 181113501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | M3340 (Texas) | Primary |
| 207R00000X | Internal Medicine | M3340 (Texas) | Secondary |
| Entity Name | East Texas Medical Center Healthcare Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124062484 PECOS PAC ID: 3678486222 Enrollment ID: O20031114000152 |
News Archive
The Vertical Expandable Prosthetic Titanium Rib (VEPTR), a device that has saved the lives of 300 infants and young children who otherwise would have died from lack of breath, has been approved by the U.S. Food and Drug Administration (FDA).
For generations, passionate kisses immortalized in movies, songs and the arts have served as a thermometer of romantic affection.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.
› Verified 2 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
The Vertical Expandable Prosthetic Titanium Rib (VEPTR), a device that has saved the lives of 300 infants and young children who otherwise would have died from lack of breath, has been approved by the U.S. Food and Drug Administration (FDA).
For generations, passionate kisses immortalized in movies, songs and the arts have served as a thermometer of romantic affection.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20100317001021 |
News Archive
The Vertical Expandable Prosthetic Titanium Rib (VEPTR), a device that has saved the lives of 300 infants and young children who otherwise would have died from lack of breath, has been approved by the U.S. Food and Drug Administration (FDA).
For generations, passionate kisses immortalized in movies, songs and the arts have served as a thermometer of romantic affection.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andy Truong Nguyen, MD 14131 Midway Rd, Suite 620, Addison, TX 75001-3623 Ph: (972) 249-0200 | Dr Andy Truong Nguyen, MD 14131 Midway Rd, Suite 620, Addison, TX 75001-3623 Ph: (972) 249-0200 |
News Archive
The Vertical Expandable Prosthetic Titanium Rib (VEPTR), a device that has saved the lives of 300 infants and young children who otherwise would have died from lack of breath, has been approved by the U.S. Food and Drug Administration (FDA).
For generations, passionate kisses immortalized in movies, songs and the arts have served as a thermometer of romantic affection.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.
› Verified 2 days ago
Snigdha Sharma, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 14131 Midway Rd, Suite 620, Addison, TX 75001 Phone: 972-249-0200 Fax: 972-249-0206 |